Markets:

Overview

News

Currencies

International

Treasuries

Bio-Path Holdings, Inc. - Common Stock (NQ:BPTH)

0.2100 UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Bio-Path Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Earnings Scheduled For May 17, 2022 ↗

May 17, 2022

Companies Reporting Before The Bell • On Holding (NYSE:ONON) is likely to report earnings for its first quarter.

Via Benzinga

A Preview Of Bio-Path Holdings's Earnings ↗

May 16, 2022

Bio-Path Holdings (NASDAQ:BPTH) is set to give its latest quarterly earnings report on Tuesday, 2022-05-17. Here's what investors need to know before the announcement. Analysts estimate that Bio-Path...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 13, 2022

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

April 13, 2022

Rise and shine, trader! Join me today as we break down all the news behind the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

Why Bio-Path Holdings Shares Are Rising After Hours ↗

April 12, 2022

Bio-Path Holdings Inc (NASDAQ: BPTH) shares are trading higher in Tuesday's after-hours session following the company's BP1003 data presentation at the 2022 American Association for Cancer Research...

Via Benzinga

The Daily Biotech Pulse: Valneva Gains On COVID Shot Regulatory Update, Lucira Health And Clearside Jump On Earnings, BeiGene Drug Snags Approval In China ↗

March 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Valneva Says Confident Of Conditional Approval For COVID Vaccine Candidate In...

Via Benzinga

Bio-Path Holdings: Q4 Earnings Insights ↗

March 11, 2022

Bio-Path Holdings (NASDAQ:BPTH) reported its Q4 earnings results on Friday, March 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

Earnings Scheduled For March 11, 2022 ↗

March 11, 2022

Companies Reporting Before The Bell • The Real Good Food (NASDAQ:RGF) is estimated to report quarterly loss at $0.19 per share on revenue of $25.29 million. •...

Via Benzinga

Earnings Preview: Bio-Path Holdings ↗

March 10, 2022

Bio-Path Holdings (NASDAQ:BPTH) is set to give its latest quarterly earnings report on Friday, 2022-03-11. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

40 Stocks Moving In Monday's Mid-Day Session ↗

December 13, 2021

Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction....

Via Benzinga

58 Biggest Movers From Yesterday ↗

December 14, 2021

Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-...

Via Benzinga

22 Stocks Moving in Monday's Pre-Market Session ↗

December 13, 2021

Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 32.6% to $3.58 in pre-market trading after gaining more than 14% on Friday. Foghorn Therapeutics Inc. (NASDAQ: FHTX) rose...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 08, 2021

Gainers Lexaria Bioscience (NASDAQ:LEXX) shares increased by 30.28% to $6.41 during Wednesday's pre-market session. The company's market cap stands at $36.7...

Via Benzinga

The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More ↗

December 06, 2021

The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 19, 2021

Gainers CASI Pharmaceuticals (NASDAQ:CASI

Via Benzinga

Earnings Scheduled For November 12, 2021 ↗

November 12, 2021

Companies Reporting Before The Bell • Zevia (NYSE:ZVIA) is estimated to report quarterly loss at $0.43 per share on revenue of $34.40 million. • Natura &Co...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 27, 2021

Gainers Bio-Path Holdings (NASDAQ:BPTH) shares moved upwards by 9.69% to $5.43 during Wednesday's pre-market session. The company's market cap stands at $37.7...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 02, 2021

Gainers Cellect Biotechnology (NASDAQ:APOP

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 31, 2021

Gainers Sonnet BioTherapeutics (NASDAQ:SONN

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 25, 2021

Gainers Regencell Bioscience (NASDAQ:RGC) stock rose 100.19% to $30.63 during Wednesday's regular session. Regencell Bioscience's stock is trading at a volume of 8...

Via Benzinga

60 Biggest Movers From Yesterday ↗

August 25, 2021

Gainers Triple-S Management Corporation (NYSE: GTS) shares surged 45.5% to close at $35.20 on Tuesday. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 24, 2021

Gainers Regencell Bioscience (NASDAQ:RGC)...

Via Benzinga

BPTH Stock: The Good News That Has BioPath Investors Smiling Today ↗

August 24, 2021

BioPath (BPTH) stock is soaring higher on Tuesday after revealing an update from the FDA on its IND application for BP1002.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 24, 2021

Gainers Triple-S Management (NYSE:GTS) shares moved upwards by 45.3% to $35.15 during Tuesday's regular session. As of 12:30 EST, Triple-S Management's stock is...

Via Benzinga

Mid-Day Market Update: Crude Oil Rises Over 2%; Theravance Biopharma Shares Slide ↗

August 24, 2021

Midway through trading Tuesday, the Dow traded up 0.09% to 35,368.20 while the NASDAQ rose 0.40% to 15,001.95. The S&P also rose, gaining 0.14% to 4,486.01. The U.S. has the...

Via Benzinga

Topics Stocks

38 Stocks Moving In Tuesday's Mid-Day Session ↗

August 24, 2021

Gainers Triple-S Management Corporation (NYSE: GTS) shares jumped 45.3% to $35.15. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield of Florida Inc,...

Via Benzinga

BPTH Stock: Why Little-Known Bio-Path Holding Just Popped More Than 20% ↗

August 24, 2021

BPTH stock is shooting up this morning as the company reveals a new plan for evaluating the effectiveness of one of its drugs.

Via InvestorPlace

Why Bio-Path Holdings Shares Are Surging Higher Today ↗

August 24, 2021

Bio-Path Holdings Inc (NASDAQ: BPTH) is surging higher Tuesday after the company announced the U.S Food and Drug Administration reviewed and cleared its ...

Via Benzinga

Mid-Morning Market Update: Markets Edge Higher; Best Buy Earnings Top Estimates ↗

August 24, 2021

Following the market opening Tuesday, the Dow traded up 0.11% to 35,374.12 while the NASDAQ rose 0.43% to 15,006.17. The S&P also rose, gaining 0.22% to 4,489.23. The U.S. has...

Via Benzinga

Topics Stocks

Why Bio-Path Shares Are Moving Higher In Premarket Tuesday? ↗

August 24, 2021

The FDA has signed off Bio-Path Holdings Inc's (NASDAQ: BPTH) Investigational New Drug (IND) application for BP1002 in refractory/relapsed acute myeloid...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Bio-Path Holdings, Inc. - Common Stock (NQ:BPTH)

Headline News about Bio-Path Holdings, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today